AMETOP

This brand name is authorized in Canada, Ireland, New Zealand, United Kingdom, South Africa

Active ingredients

The drug AMETOP contains one active pharmaceutical ingredient (API):

1 Tetracaine UNII 5NF5D4OPCI - TETRACAINE HYDROCHLORIDE

Tetracaine is a local anaesthetic and is believed to act by blocking nerve conduction mainly by inhibiting sodium ion flux across the axon membrane. Read about Tetracaine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AMETOP 4% w/w Gel	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D04AB06	Tetracaine	D Dermatologicals → D04 Antipruritics, incl. antihistamines, anesthetics, etc. → D04A Antipruritics, incl. antihistamines, anesthetics, etc. → D04AB Anesthetics for topical use
Discover more medicines within D04AB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02230575
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 37186, 89689, 89690
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7884
Country: ZA	Health Products Regulatory Authority	Identifier(s): 31/4/0157